Three insights:
1. The biomaterial is a cell-driven matrix gel that can be injected into the spinal disc and repair disc volume and height, which would ease pain in patients suffering from degenerative disc disease.
2. It will also offer a scaffold for autologous cellular regeneration of the disc core.
3. The biomaterial contains swelling properties which allow it to soak up fluid and expand, rejuvenating the pressure inside the disc to achieve the same height pre-degeneration.
More articles on biologics:
Biomaterials startup raises $500K for scaffolds to treat spinal cord injuries
Dr. Robert LaPrade on the biggest thing to hit sports medicine since the arthroscope
Ossio wins Frost & Sullivan award for bone regeneration technology — 4 insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
